Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
2.
Support Care Cancer ; 28(5): 2457-2472, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32056010

RESUMEN

OBJECTIVE: To update the clinical practice guidelines for the management of oral mucositis (OM) that were developed by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). This part focuses on honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. METHODS: A systematic review was conducted by the Mucositis Study Group of MASCC/ISOO. The body of evidence for each intervention, in each clinical setting, was assigned an evidence level. The findings were added to the database used to develop the 2014 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following guidelines were determined: Recommendation, Suggestion, No Guideline Possible. RESULTS: A total of 78 papers were identified within the scope of this section, of which 49 were included in this review and merged with nine publications that were reported in the previous guidelines update. A new Suggestion was made for honey (combined topical and systemic delivery) for the prevention of OM in head and neck cancer patients receiving radiotherapy with or without chemotherapy. A new Suggestion clarified that chewing gum is not effective for the prevention of OM in pediatric patients with hematological or solid cancer treated with chemotherapy. No guideline was possible for other interventions. CONCLUSIONS: Numerous natural products and herbal remedies were studied for the management of OM. Of the agents reviewed in this systematic review, a guideline in favor was made for honey (combined topical and systemic), while a guideline against was made for chewing gum. Additional research is warranted to clarify the potential of other interventions.


Asunto(s)
Miel , Mucositis/tratamiento farmacológico , Plantas Medicinales , Probióticos/uso terapéutico , Saliva/metabolismo , Estomatitis/tratamiento farmacológico , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Estimulantes del Sistema Nervioso Central/uso terapéutico , Goma de Mascar , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Humanos , Saliva/efectos de los fármacos
3.
Support Care Cancer ; 27(10): 3969-3983, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31286228

RESUMEN

PURPOSE: To systematically review the literature and update the evidence-based clinical practice guidelines for the use of photobiomodulation (PBM), such as laser and other light therapies, for the prevention and/or treatment of oral mucositis (OM). METHODS: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) using PubMed and Web of Science. We followed the MASCC methods for systematic review and guidelines development. The rigorously evaluated evidence for each intervention, in each cancer treatment setting, was assigned a level-of-evidence (LoE). Based on the LoE, one of the following guidelines was determined: Recommendation, Suggestion, or No Guideline Possible. RESULTS: Recommendations are made for the prevention of OM and related pain with PBM therapy in cancer patients treated with one of the following modalities: hematopoietic stem cell transplantation, head and neck (H&N) radiotherapy (without chemotherapy), and H&N radiotherapy with chemotherapy. For each of these modalities, we recommend 1-2 clinically effective protocols; the clinician should adhere to all parameters of the protocol selected. Due to inadequate evidence, currently, No Guideline Possible for treatment of established OM or for management of chemotherapy-related OM. The reported clinical settings were extremely variable, limiting data integration. CONCLUSIONS: The evidence supports the use of specific settings of PBM therapy for the prevention of OM in specific patient populations. Under these circumstances, PBM is recommended for the prevention of OM. The guidelines are subject to continuous update based on new published data.


Asunto(s)
Terapia por Luz de Baja Intensidad/métodos , Mucositis/terapia , Guías de Práctica Clínica como Asunto , Estomatitis/prevención & control , Estomatitis/terapia , Protocolos Clínicos , Humanos , Masculino , Neoplasias/terapia
4.
Support Care Cancer ; 27(10): 3997-4010, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31286229

RESUMEN

PURPOSE: To update the clinical practice guidelines for the use of natural and miscellaneous agents for the prevention and/or treatment of oral mucositis (OM). METHODS: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. The findings were added to the database used to develop the 2014 MASCC/ISOO clinical practice guidelines. Based on the evidence level, the following guidelines were determined: Recommendation, Suggestion, and No Guideline Possible. RESULTS: A total of 78 papers were identified within the scope of this section, out of which 29 were included in this part, and were analyzed with 27 previously reviewed studies. A new Suggestion was made for oral glutamine for the prevention of OM in head and neck (H&N) cancer patients receiving radiotherapy with concomitant chemotherapy. The previous Recommendation against the use of parenteral glutamine for the prevention of OM in hematopoietic stem cell transplantation (HSCT) patients was re-established. A previous Suggestion for zinc to prevent OM in H&N cancer patients treated with radiotherapy or chemo-radiotherapy was reversed to No Guideline Possible. No guideline was possible for other interventions. CONCLUSIONS: Of the vitamins, minerals, and nutritional supplements studied for the management of OM, the evidence supports a Recommendation against parenteral glutamine in HSCT patients and a Suggestion in favor of oral glutamine in H&N cancer patients for the management of OM.


Asunto(s)
Glutamina/uso terapéutico , Minerales/uso terapéutico , Mucositis/tratamiento farmacológico , Mucositis/prevención & control , Estomatitis/tratamiento farmacológico , Estomatitis/prevención & control , Vitaminas/uso terapéutico , Suplementos Dietéticos , Glutamina/administración & dosificación , Neoplasias de Cabeza y Cuello/terapia , Humanos , Neoplasias/tratamiento farmacológico
5.
Support Care Cancer ; 27(10): 4011-4022, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31286233

RESUMEN

PURPOSE: The aim of this study was to update the clinical practice guidelines for the use of agents for the prevention and/or treatment of gastrointestinal mucositis (GIM). METHODS: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, and No Guideline Possible. RESULTS: A total of 78 papers across 13 interventions were examined of which 25 were included in the final review. No new guidelines were possible for any agent due to inadequate and/or conflicting evidence. Existing guidelines for probiotics and hyperbaric oxygen were unchanged. CONCLUSIONS: Of the agents studied for the prevention and treatment of GIM, the evidence continues to support use of probiotics containing Lactobacillus spp. for prevention of chemoradiotherapy and radiotherapy-induced diarrhea in patients with pelvic malignancy, and hyperbaric oxygen therapy to treat radiation-induced proctitis. Additional well-designed research is encouraged to enable a decision regarding palifermin, glutamine, sodium butyrate, and dietary interventions, for the prevention or treatment of GIM.


Asunto(s)
Quimioradioterapia/efectos adversos , Mucositis/tratamiento farmacológico , Mucositis/prevención & control , Guías de Práctica Clínica como Asunto , Proctitis/tratamiento farmacológico , Estomatitis/tratamiento farmacológico , Ácido Butírico/uso terapéutico , Factor 7 de Crecimiento de Fibroblastos/uso terapéutico , Glutamina/uso terapéutico , Humanos , Oxigenoterapia Hiperbárica , Neoplasias/tratamiento farmacológico
6.
Int J Nurs Pract ; 21 Suppl 2: 115-24, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-26125579

RESUMEN

This paper summarizes evidence on effectiveness of diabetes self-care interventions for older adults with diabetes, and identifies factors influencing self-care behaviours. The search for articles published from 2002 to 2012 was done using electronic databases, namely, MEDLINE, CINAHL, Scopus, PsycINFO and PubMed. Search terms include diabetes, self-management, self-care, barriers and intervention. Out of 261 articles screened, 21 were selected for review. Findings revealed that interventions using concepts of self-efficacy, self-determination and proactive coping, and interventions incorporating information technology were effective in influencing diabetes self-care behaviours with improved health outcomes. Psychosocial factors influencing self-care include motivation, socioeconomic status, literacy, knowledge, social and health-care providers' support, and particularly for older adults, the key factors were their self-efficacy, motor skill and literacy in self-care activities. This review provides important insight for nurse practitioners to address psychosocial issues in developing self-care management programmes for older adults with diabetes.


Asunto(s)
Diabetes Mellitus/terapia , Autocuidado , Factores de Edad , Anciano , Anciano de 80 o más Años , Humanos
7.
Support Care Cancer ; 17(7): 829-37, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19322593

RESUMEN

GOAL: The purpose of this qualitative phenomenological study was to describe children's and their parents' lived experiences of oral mucositis (OM) and to explore their needs in relation to OM. MATERIALS AND METHODS: Individual semistructured interviews were conducted with 22 children who had experienced WHO grade > or = 2 OM during chemotherapy within the previous 6 months. Parents from each family were also interviewed in the same way. Interviews were audio recorded and fully transcribed verbatim. Data were analyzed using inductive content analysis. RESULTS: The mean ages of the children and parents were 12 and 41 years, respectively. Regarding gender, 55% of the children were boys, and 95% of the parents were mothers or grandmother. Forty-one percent of the children were diagnosed with acute lymphoblastic leukemia, and 36% were treated with methotrexate. The findings illustrated that the experience of OM impacted on the lives of the children and their parents. Five themes, which subsumed a number of categories, were constructed: "Symptoms experienced," "Negative emotional outcomes," "The dilemma of eating (or not eating)," "Challenges in oral care," "Health care needs." Mouth and throat pain were found to cause a number of severe consequences in daily life. Many children experienced turmoil characterized by a panoply of emotions. All parents described psychological distress on various levels which they attributed to the burden of care and the suffering of their children. OM can present a difficult dilemma to patients: on the one hand, children found it too painful to chew and swallow food, while on the other hand they felt very hungry. Children were aware of the significance of oral care. Discomfort associated with oral care forced some children to neglect oral care. Parents also described oral care as a stressful event for their children and for them. Children needed more activities coordinated by the ward to distract them from their OM, as well as psychological support from the health care professionals. Parents indicated the need for more information about the process of OM and food selection. CONCLUSION: Findings from this study illustrate the complex biopsychosocial impact of chemotherapy-induced OM on children and their parents. Optimal OM pain management guidelines and holistic supportive care strategies should be developed in conjunction with OM strategies in the future.


Asunto(s)
Antineoplásicos/efectos adversos , Necesidades y Demandas de Servicios de Salud , Neoplasias/tratamiento farmacológico , Estomatitis/fisiopatología , Adolescente , Adulto , Antineoplásicos/uso terapéutico , Niño , Recolección de Datos , Ingestión de Alimentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Higiene Bucal , Padres/psicología , Educación del Paciente como Asunto , Estomatitis/inducido químicamente , Estomatitis/psicología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA